"These cells are reprogrammed from existing cells and represent a promising unlimited source for generating patient-specific cells for biomedical research and personalized medicine," said the lead author of the study, Xianmin Zeng, Ph.D. "Human iPSCs may provide an end-run around immuno-rejection issues surrounding the use of human embryonic stem cells (hESCs) to treat disease. They may also solve bioethical issues surrounding hESCs."
The team of scientists transplanted iPSC-derived neurons into rats that had mid-brain injury similar to that found in human PD. The cells became functional and the rats showed improvement in their motor skills.
quote: Anand used to be the #1 place to go for all things tech, and now all the blatant political and ecological bias makes me want to puke.